Latest filing published 23 Mar 2026 for REPLIGEN CORP.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James Bylund, listed as senior executive, appears in our data through filings on Repligen Corp shares, published by SEC (Form 4). The record holds 36 filings, for trades running from 6 April 2021 to 5 March 2026.
Every open-market trade on record is a sale: 4 sales worth €1.6M. Outside the open market, there are 30 share grants and 2 option exercises.
Most recently, on 23 March 2026, the filings show a share grant in Repligen Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations